Clinical Lung Cancer

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/authors/author-servicesauthor services.

Please see our http://www.elsevier.com/journals/clinical-lung-cancer/1525-7304/guide-for-authorsGuide for Authors for information on article submission. If you require any further information or help, please visit our http://service.elsevier.com/app/home/supporthub/publishing/Support Center